Published on Fri May 10 2019

EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy.

G J Sturm, E-M Varga, G Roberts, H Mosbech, M B Bilò, C A Akdis, D Antolín-Amérigo, E Cichocka-Jarosz, R Gawlik, T Jakob, M Kosnik, J Lange, E Mingomataj, D I Mitsias, M Ollert, J N G Oude Elberink, O Pfaar, C Pitsios, V Pravettoni, F Ruëff, B A Sin, I Agache, E Angier, S Arasi, M A Calderón, M Fernandez-Rivas, S Halken, M Jutel, S Lau, G B Pajno, R van Ree, D Ryan, O Spranger, R G van Wijk, S Dhami, H Zaman, A Sheikh, A Muraro

Systemic-allergic sting reactions have been reported in up to 7.5% of adults and up to 3.4% of children. Patients should carry an emergency kit containing an adrenaline autoinjector.

1
1
1
Abstract

Hymenoptera venom allergy is a potentially life-threatening allergic reaction following a honeybee, vespid, or ant sting. Systemic-allergic sting reactions have been reported in up to 7.5% of adults and up to 3.4% of children. They can be mild and restricted to the skin or moderate to severe with a risk of life-threatening anaphylaxis. Patients should carry an emergency kit containing an adrenaline autoinjector, H